10,395 Shares in Koninklijke Philips (NYSE:PHG) Purchased by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors bought a new stake in Koninklijke Philips (NYSE:PHG - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund bought 10,395 shares of the technology company's stock, valued at approximately $263,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Wilmington Savings Fund Society FSB purchased a new position in Koninklijke Philips in the third quarter valued at $54,000. Eastern Bank purchased a new position in shares of Koninklijke Philips in the 3rd quarter valued at about $88,000. Allworth Financial LP grew its position in shares of Koninklijke Philips by 24.9% during the fourth quarter. Allworth Financial LP now owns 3,993 shares of the technology company's stock worth $105,000 after buying an additional 797 shares in the last quarter. RPg Family Wealth Advisory LLC purchased a new stake in shares of Koninklijke Philips during the third quarter worth approximately $107,000. Finally, OLD National Bancorp IN acquired a new stake in Koninklijke Philips in the third quarter valued at approximately $202,000. 13.67% of the stock is currently owned by hedge funds and other institutional investors.

Koninklijke Philips Stock Up 1.8 %

Shares of Koninklijke Philips stock traded up $0.46 during trading hours on Monday, hitting $26.01. The company had a trading volume of 1,798,147 shares, compared to its average volume of 746,373. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.23 and a quick ratio of 0.74. The company's 50-day moving average is $26.25 and its two-hundred day moving average is $28.11. The company has a market cap of $24.44 billion, a P/E ratio of -30.96, a price-to-earnings-growth ratio of 0.82 and a beta of 0.77. Koninklijke Philips has a twelve month low of $19.75 and a twelve month high of $32.91.

Koninklijke Philips (NYSE:PHG - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The company had revenue of $5.38 billion during the quarter, compared to analyst estimates of $5.10 billion. Analysts anticipate that Koninklijke Philips will post 1.63 earnings per share for the current fiscal year.

Koninklijke Philips Cuts Dividend

The company also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Shareholders of record on Tuesday, May 13th will be paid a $0.886 dividend. This represents a yield of 2.9%. The ex-dividend date of this dividend is Tuesday, May 13th. Koninklijke Philips's dividend payout ratio is currently -108.33%.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on PHG shares. Jefferies Financial Group raised shares of Koninklijke Philips from an "underperform" rating to a "hold" rating in a research report on Tuesday, October 29th. UBS Group upgraded Koninklijke Philips from a "neutral" rating to a "buy" rating in a research note on Thursday. Finally, StockNews.com raised Koninklijke Philips from a "hold" rating to a "buy" rating in a research report on Thursday. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy".

About Koninklijke Philips

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.